| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 23.42 |
|
ISIN Demat : INE059A01026 |
Div & Yield% : 1.06 |
EPS(TTM) : 64.35 |
|
Book Value(₹) : 411.56 |
Market Cap(₹Cr) : 121,751.32 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 4,495.16 | 4,501.66 | 4,254.47 | 4,134.87 | 3,969.86 | 3,752.25 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,495.16 | 4,501.66 | 4,254.47 | 4,134.87 | 3,969.86 | 3,752.25 |
| Other Operating Income | 730.56 | 544.51 | 543.42 | 836.01 | 805.17 | 748.80 |
| Other Income | 254.66 | 271.07 | 588.03 | 188.69 | 289.14 | 213.52 |
| Total Income | 5,480.38 | 5,317.24 | 5,385.92 | 5,159.57 | 5,064.17 | 4,714.57 |
| Total Expenditure | 3,703.09 | 3,421.72 | 3,479.18 | 3,309.05 | 3,336.99 | 3,141.19 |
| PBIDT | 1,777.29 | 1,895.52 | 1,906.74 | 1,850.52 | 1,727.18 | 1,573.38 |
| Interest | 2.65 | 5.88 | 3.49 | 3.55 | 3.00 | 5.07 |
| PBDT | 1,774.64 | 1,889.64 | 1,903.25 | 1,846.97 | 1,724.18 | 1,568.31 |
| Depreciation | 141.30 | 145.69 | 147.70 | 142.62 | 145.71 | 137.86 |
| Tax | 412.22 | 456.04 | 332.71 | 262.96 | 406.73 | 357.92 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 10.59 | -15.22 | -62.56 | 3.24 | -6.42 | 16.59 |
| Reported Profit After Tax | 1,210.53 | 1,303.13 | 1,485.40 | 1,438.15 | 1,178.16 | 1,055.94 |
| Extra-ordinary Items | 0.00 | 0.00 | 238.82 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1,210.53 | 1,303.13 | 1,246.58 | 1,438.15 | 1,178.16 | 1,055.94 |
| EPS (Unit Curr.) | 14.99 | 16.13 | 18.39 | 17.81 | 14.59 | 13.08 |
| EPS (Adj) (Unit Curr.) | 14.99 | 16.13 | 18.39 | 17.81 | 14.59 | 13.08 |
| Calculated EPS (Unit Curr.) | 14.99 | 16.13 | 18.39 | 17.81 | 14.59 | 13.08 |
| Calculated EPS (Adj) (Unit Curr.) | 14.99 | 16.13 | 18.39 | 17.81 | 14.59 | 13.08 |
| Calculated EPS (Ann.) (Unit Curr.) | 59.95 | 64.53 | 73.57 | 71.23 | 58.36 | 52.31 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 59.95 | 64.53 | 73.57 | 71.23 | 58.36 | 52.31 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 161.55 | 161.55 | 161.52 | 161.52 | 161.51 | 161.50 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 39.54 | 42.11 | 44.82 | 44.75 | 43.51 | 41.93 |
| PBDTM(%) | 39.48 | 41.98 | 44.74 | 44.67 | 43.43 | 41.80 |
| PATM(%) | 26.93 | 28.95 | 34.91 | 34.78 | 29.68 | 28.14 |